Kentucky Trust Company |
Retirement Plan Administrator (TPA) Retirement Plan Consultants |
Retirement, LLC |
Administrator/Consultant (DC and DB) TPA Professionals |
EPIC Retirement Plan Services |
Pentegra |
Retirement Plan Administrator – Senior Associate PBMares |
Employee Benefits and Executive Compensation Associate Attorney Verrill |
Jr Retirement Plan Administrator/ Administrative Assistant Hochheiser Deutsch & Co, Inc. |
Farmer & Betts, Inc. |
Retirement Plan Legal Specialist Pentegra |
Nicholas Pension Consultants |
Plumbers Local Union No. 1 Benefit Funds |
Retirement Plan Documents Specialist Loren D. Stark Company |
Employee Benefits & Executive Compensation Associate Attorney Polsinelli PC |
Retirement Plan Relationship Manager ERISA Services, Inc. |
Retirement, LLC |
RTD Financial Advisors |
EPIC: TPA/DPS |
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
| |
<< Previous news item | Next news item >>
Insurers Push to Link Cost of Drugs to Performance The Boston Globe ![]() June 12, 2015 "Health insurers are pushing to link the cost of specialty medicines to how well they work to improve a patient's condition, a bid to contain prescription drug prices after decades in which pharmaceutical companies could charge whatever the market would bear. The shift is coming as insurers absorb mounting bills for drugs with eye-popping prices and brace for a slew of new therapies for diseases such as hepatitis C, cystic fibrosis, breast cancer, lung cancer, and leukemia. Those emerging treatments could cost US government-paid health programs such as Medicare nearly $50 billion over the next decade[.]" |
Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the link above). |
An important word about authorship: BenefitsLink® is providing a hypertext link to the item shown above, but is not the author of the item (unless otherwise specified). |